0001179110-14-008766.txt : 20140519 0001179110-14-008766.hdr.sgml : 20140519 20140519190630 ACCESSION NUMBER: 0001179110-14-008766 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140515 FILED AS OF DATE: 20140519 DATE AS OF CHANGE: 20140519 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theravance Biopharma, Inc. CENTRAL INDEX KEY: 0001583107 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 650-808-6000 MAIL ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36033 FILM NUMBER: 14856005 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER NAME: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 edgar.xml FORM 4 - X0306 4 2014-05-15 0 0001583107 Theravance Biopharma, Inc. TBPH 0001080014 THERAVANCE INC 901 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 0 0 1 0 Common Stock 2014-05-15 4 J 0 33100000 0 D 0 D As of the date of this report, Theravance Biopharma, Inc. ("TBPH") is a wholly owned subsidiary of Theravance, Inc. ("THRX"). On June 2, 2014, THRX will distribute to its stockholders one ordinary share of TBPH for every 3.5 common shares of THRX that were outstanding at 5:00 p.m. Eastern Time on May 15, 2014, the record date for the distribution. Any TBPH ordinary shares held by THRX that are not distributed in the stock dividend will be surrendered by THRX to TBPH for no consideration and will not be outstanding immediately following the dividend. Bradford J Shafer, General Counsel and Secretary 2014-05-19